The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oral Proteins and Peptides Market Research Report 2025

Global Oral Proteins and Peptides Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1429755

No of Pages : 81

Ask Your Query

Synopsis

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

The global Oral Proteins and Peptides market was valued at US$ 2503.5 million in 2023 and is anticipated to reach US$ 6889.3 million by 2030, witnessing a CAGR of 15.1% during the forecast period 2024-2030.

Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

This report aims to provide a comprehensive presentation of the global market for Oral Proteins and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Proteins and Peptides.

Report Scope

The Oral Proteins and Peptides market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Proteins and Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Proteins and Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Ironwood & Allergan
  • Novo Nordisk
  • Synergy Pharmaceuticals （Salix）
  • Novartis
  • Chiasma (Amryt Pharma)

Segment by Type

  • Linaclotide
  • Insulin
  • Plecanatide
  • Cyclosporine
  • Octreotide

Segment by Application

  • Gastric & Digestive Disorders
  • Bone Diseases
  • Diabetes
  • Hormonal Disorders

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Proteins and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Oral Proteins and Peptides Market Overview
1.1 Product Overview and Scope of Oral Proteins and Peptides
1.2 Oral Proteins and Peptides Segment by Type
1.2.1 Global Oral Proteins and Peptides Market Value Comparison by Type (2024-2030)
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Oral Proteins and Peptides Segment by Application
1.3.1 Global Oral Proteins and Peptides Market Value by Application: (2024-2030)
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Global Oral Proteins and Peptides Market Size Estimates and Forecasts
1.4.1 Global Oral Proteins and Peptides Revenue 2019-2030
1.4.2 Global Oral Proteins and Peptides Sales 2019-2030
1.4.3 Global Oral Proteins and Peptides Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Proteins and Peptides Market Competition by Manufacturers
2.1 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2019-2024)
2.4 Global Oral Proteins and Peptides Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Proteins and Peptides, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Proteins and Peptides, Product Type & Application
2.7 Oral Proteins and Peptides Market Competitive Situation and Trends
2.7.1 Oral Proteins and Peptides Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Proteins and Peptides Players Market Share by Revenue
2.7.3 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Proteins and Peptides Retrospective Market Scenario by Region
3.1 Global Oral Proteins and Peptides Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Proteins and Peptides Global Oral Proteins and Peptides Sales by Region: 2019-2030
3.2.1 Global Oral Proteins and Peptides Sales by Region: 2019-2024
3.2.2 Global Oral Proteins and Peptides Sales by Region: 2025-2030
3.3 Global Oral Proteins and Peptides Global Oral Proteins and Peptides Revenue by Region: 2019-2030
3.3.1 Global Oral Proteins and Peptides Revenue by Region: 2019-2024
3.3.2 Global Oral Proteins and Peptides Revenue by Region: 2025-2030
3.4 North America Oral Proteins and Peptides Market Facts & Figures by Country
3.4.1 North America Oral Proteins and Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Proteins and Peptides Sales by Country (2019-2030)
3.4.3 North America Oral Proteins and Peptides Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Proteins and Peptides Market Facts & Figures by Country
3.5.1 Europe Oral Proteins and Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Proteins and Peptides Sales by Country (2019-2030)
3.5.3 Europe Oral Proteins and Peptides Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Proteins and Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Proteins and Peptides Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Proteins and Peptides Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Proteins and Peptides Market Facts & Figures by Country
3.7.1 Latin America Oral Proteins and Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Proteins and Peptides Sales by Country (2019-2030)
3.7.3 Latin America Oral Proteins and Peptides Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Proteins and Peptides Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Proteins and Peptides Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Proteins and Peptides Sales by Type (2019-2030)
4.1.1 Global Oral Proteins and Peptides Sales by Type (2019-2024)
4.1.2 Global Oral Proteins and Peptides Sales by Type (2025-2030)
4.1.3 Global Oral Proteins and Peptides Sales Market Share by Type (2019-2030)
4.2 Global Oral Proteins and Peptides Revenue by Type (2019-2030)
4.2.1 Global Oral Proteins and Peptides Revenue by Type (2019-2024)
4.2.2 Global Oral Proteins and Peptides Revenue by Type (2025-2030)
4.2.3 Global Oral Proteins and Peptides Revenue Market Share by Type (2019-2030)
4.3 Global Oral Proteins and Peptides Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Proteins and Peptides Sales by Application (2019-2030)
5.1.1 Global Oral Proteins and Peptides Sales by Application (2019-2024)
5.1.2 Global Oral Proteins and Peptides Sales by Application (2025-2030)
5.1.3 Global Oral Proteins and Peptides Sales Market Share by Application (2019-2030)
5.2 Global Oral Proteins and Peptides Revenue by Application (2019-2030)
5.2.1 Global Oral Proteins and Peptides Revenue by Application (2019-2024)
5.2.2 Global Oral Proteins and Peptides Revenue by Application (2025-2030)
5.2.3 Global Oral Proteins and Peptides Revenue Market Share by Application (2019-2030)
5.3 Global Oral Proteins and Peptides Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ironwood & Allergan
6.1.1 Ironwood & Allergan Corporation Information
6.1.2 Ironwood & Allergan Description and Business Overview
6.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio
6.1.5 Ironwood & Allergan Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Synergy Pharmaceuticals （Salix）
6.3.1 Synergy Pharmaceuticals （Salix） Corporation Information
6.3.2 Synergy Pharmaceuticals （Salix） Description and Business Overview
6.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio
6.3.5 Synergy Pharmaceuticals （Salix） Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Oral Proteins and Peptides Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Chiasma (Amryt Pharma)
6.5.1 Chiasma (Amryt Pharma) Corporation Information
6.5.2 Chiasma (Amryt Pharma) Description and Business Overview
6.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
6.5.5 Chiasma (Amryt Pharma) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Proteins and Peptides Industry Chain Analysis
7.2 Oral Proteins and Peptides Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Proteins and Peptides Production Mode & Process
7.4 Oral Proteins and Peptides Sales and Marketing
7.4.1 Oral Proteins and Peptides Sales Channels
7.4.2 Oral Proteins and Peptides Distributors
7.5 Oral Proteins and Peptides Customers
8 Oral Proteins and Peptides Market Dynamics
8.1 Oral Proteins and Peptides Industry Trends
8.2 Oral Proteins and Peptides Market Drivers
8.3 Oral Proteins and Peptides Market Challenges
8.4 Oral Proteins and Peptides Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock